Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8241720 | International Journal of Radiation Oncology*Biology*Physics | 2007 | 7 Pages |
Abstract
Conclusion: Plasma EBV DNA is the most valuable prognostic factor for NPC. More chemotherapy should be considered for patients with persistently detectable EBV DNA after CCRT.
Keywords
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Jin-Ching M.D., Ph.D., Wen-Yi Ph.D., Wen-Miin Ph.D., Hsin-Yi M.S., Jian-Sheng M.D., Rong-San M.D., Ju-Yu Ph.D., Chih-Wen M.D., Kai-Li M.D., Jeffrey M.D., Wu-Chung M.D.,